Risk of cervical precancer and cancer in women with cervical intraepithelial neoplasia grade 1 on endocervical curettage

Journal of Lower Genital Tract Disease

Volumn 17, Issue 3, 2013, Pages 255-260

  Fukuchi, Emily ^a   Fetterman, Barbara ^b   Poitras, Nancy ^b   Kinney, Walter ^c   Lorey, Thomas ^b   Littell, Ramey D ^c  

^a Kaiser Permanente ^*  (United States)

^b Regional Laboratory   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Cervical cancer screening; CIN 1; Colposcopy; Endocervical curettage

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SCREENING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CURETTAGE; ENDOCERVICAL CURETTAGE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; UTERINE CERVIX CARCINOMA IN SITU;

ADENOCARCINOMA; ADULT; CALIFORNIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CURETTAGE; FEMALE; HUMANS; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS;

EID: 84880346722     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31826ca4d9     Document Type: Article

References (28)

1. Fine BA, Feinstein GI, Sabella V. The pre-and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer. Gynecol Oncol 1998;71:46-9.
2. Petersen S, Belnap C, Larsen WI, Farley J. Grading of squamous dysplasia in endocervical curettage specimens: the case for conservative management of mild endocervical dysplasia. J Reprod Med 2007;52:917-21.
3. Glazer JD, Benrubi GI, Nuss RC. Positive results of endocervical curettage as an indication for conization of the cervix. South Med J 1987;80:185-6.
4. Grainger DA, Roberts DK, Wells MM, Horbelt DV. The value of endocervical curettage in the management of the patient with abnormal cervical cytologic findings. Am J Obstet Gynecol 1987;156:625-8.
5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma insitu. AmJObstetGynecol 2007;197:340-5.
6. Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol 2009;113: 595-600.
7. MoniakCW, Kutzner S, AdamE, Harden J, KaufmanRH. Endocervical curettage in evaluating abnormal cervical cytology. J Reprod Med 2000;45:285-92.
8. Husseinzadeh N, Rettig LW. Double-LEEP cone procedure as an alternative to cold-knife conization in management of cervical intraepithelial neoplasia. J Lower Gen Tract Dis 2000;4:72-5.
9. Massad LS, Chronopoulos FT, Cejtin HE. Correlating cone biopsy histology with operative indications. Gynecol Oncol 1997;65:286-90.
10. Townsend DE, Richart RM, Marks E, Nielsen J. Invasive cancer following outpatient evaluation and therapy for cervical disease. Obstet Gynecol 1981;57:145-9.
11. SpitzerM, Chernys AE, Shifrin A, RyskinM. Indications for cone biopsy: pathologic correlation. Am J Obstet Gynecol 1998;178(1 pt 1):74-9.
12. Shingleton HM, Gore H, Austin JM Jr. Outpatient evaluation of patients with atypical Papanicolaou smears: contribution of endocervical curettage. Am J Obstet Gynecol 1976;126:122-8.
13. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430-434.
14. Williams DL, Dietrich C, McBroom J. Endocervical curettage when colposcopic examination is satisfactory and normal. Obstet Gynecol 2000;95(6 pt 1):801-3.
15. Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13, 115 colposcopically guided biopsy examinations. Am J Obstet Gynecol. 2010;203:481.e1-9.
16. Rose JD, Byun SY, Sims SM, Davis JD. The utility of endocervical curettage: does routine ECC at the time of colposcopy for low-grade cytologic abnormalities improve diagnosis of high-grade disease? Am J Obstet Gynecol 2012;206: 530.e1-3.
17. Drescher CW, Peters WA 3rd, Roberts JA. Contribution of endocervical curettage in evaluating abnormal cervical cytology. Obstet Gynecol 1983;62:343-7.
18. Husseinzadeh N, Carter V, Wesseler T. Significance of positive endocervical curettage in predicting endocervical canal involvement in patients with cervical intraepithelial neoplasia. Gynecol Oncol 1989;35:358-61.
19. ALTS Study Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
20. ALTS Study Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188: 1393-400.
21. Dunn TS, Burke M, Shwayder J. A ''see and treat'' management for high-grade squamous intraepithelial lesion Pap smears. J Lower Gen Tract Dis 2003;7:104-6.
22. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol 2001;82:516-22.
23. Alvarez RD, Wright TC. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol 2007;104:281-9.
24. CastlePE, SideriM, JeronimoJ, SolomonD, SchiffmanM. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 2007;197:356.e1-6.
25. Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004;291:2100-6.
26. Sjoborg KD, Vistad I, Myhr SS, Svenningsen R, Herzog C, Kloster-Jensen A, et al. Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstet Gynecol Scand 2007;86:423-8.
27. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. Regression of low-grade squamous intraepithelial lesions in young women. Lancet 2004;364: 1678-83.
28. Cox JT, Schiffman M, Solomon D. Prospective followup suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406-12.